Key genomic alterations and potential therapeutic vulnerabilities in transformed cutaneous T-cell lymphoma
Researchers have shared a comprehensive multiomics study from a rare cohort of 56 patients with transformed CTCL and identified several genomic alterations and oncogenic programs that may be potential novel therapeutic targets.
Materials provided by H. Lee Moffitt Cancer Center & Research Institute. Note: Content may be edited for style and length.
Source link aaaaa